Macrogenics Inc (MGNX)
15.33
-0.22
(-1.41%)
USD |
NASDAQ |
May 02, 12:49
Macrogenics 1 Year Total Returns (Daily): 109.9% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | 109.9% |
April 30, 2024 | 114.5% |
April 29, 2024 | 115.1% |
April 26, 2024 | 113.5% |
April 25, 2024 | 116.4% |
April 24, 2024 | 134.3% |
April 23, 2024 | 133.5% |
April 22, 2024 | 121.7% |
April 19, 2024 | 128.6% |
April 18, 2024 | 138.1% |
April 17, 2024 | 136.1% |
April 16, 2024 | 157.0% |
April 15, 2024 | 161.0% |
April 12, 2024 | 175.8% |
April 11, 2024 | 194.0% |
April 10, 2024 | 178.2% |
April 09, 2024 | 146.6% |
April 08, 2024 | 150.0% |
April 05, 2024 | 148.2% |
April 04, 2024 | 139.0% |
April 03, 2024 | 81.30% |
April 02, 2024 | 85.63% |
April 01, 2024 | 95.54% |
March 28, 2024 | 121.4% |
March 27, 2024 | 121.6% |
Date | Value |
---|---|
March 26, 2024 | 112.9% |
March 25, 2024 | 115.7% |
March 22, 2024 | 115.8% |
March 21, 2024 | 116.2% |
March 20, 2024 | 130.0% |
March 19, 2024 | 134.3% |
March 18, 2024 | 134.6% |
March 15, 2024 | 151.3% |
March 14, 2024 | 149.0% |
March 13, 2024 | 181.6% |
March 12, 2024 | 230.8% |
March 11, 2024 | 218.4% |
March 08, 2024 | 216.9% |
March 07, 2024 | 249.4% |
March 06, 2024 | 277.3% |
March 05, 2024 | 240.0% |
March 04, 2024 | 241.4% |
March 01, 2024 | 205.9% |
February 29, 2024 | 194.6% |
February 28, 2024 | 182.3% |
February 27, 2024 | 188.6% |
February 26, 2024 | 172.4% |
February 23, 2024 | 187.5% |
February 22, 2024 | 161.2% |
February 21, 2024 | 173.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.67%
Minimum
Jun 01 2022
589.3%
Maximum
Mar 16 2021
20.49%
Average
-14.00%
Median
Nov 23 2021
1 Year Total Returns (Daily) Benchmarks
Allurion Technologies Inc | -- |
United Therapeutics Corp | 9.87% |
MEI Pharma Inc | -21.57% |
Marinus Pharmaceuticals Inc | -84.00% |
Voyager Therapeutics Inc | 15.33% |